Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Assessing Sequence Similarity between FVIII-Derived B-Cell Epitopes and Pathogen-Derived B-Cell Epitopes and the Risk of Inhibitor Development in Patients with Severe Hemophilia a

Shermarke Hassan, Guido Baselli, Roberta Palla, Frits Richard Rosendaal, Flora Peyvandi

Blood (2022) 140 (Supplement 1): 11282–11283.

https://doi.org/10.1182/blood-2022-165136

Published: 2022

Journal Articles

Factor VIII Epitope Analysis Using a Random Peptide Phage-Display Library Approach in the Sippet Cohort

Shermarke Hassan, Guido Baselli, Kaia Palm, Frits Richard Rosendaal, Roberta Palla, Flora Peyvandi

Blood (2021) 138 (Supplement 1): 3176.

https://doi.org/10.1182/blood-2021-152889

Published: 2021

Journal Articles

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Flora Peyvandi, MD PhD, Paolo Bucciarelli, MD, Carla Valsecchi, BSc, Marco Boscarino, Roberta Palla, PhD, Elena Santagostino, Amal El-Beshlawy, Mohsen Saleh Elalfy, MD, Vijay M. Ramanan, MBBS,MDDM, Peyman Eshghi, MD, Suresh Hanagavadi, MD, Mehran Karimi, MD, Cecil Ross, MD, Mamta V Manglani, MD, Guy Young, Tulika Seth, MDMBBS,FAAP, Shashikant Apte, MD FRCPA, Dinesh M Nayak, MD, Maria Elisa Mancuso, Johnny Mahlangu, Bonanad Santiago, MD, Monica H Cerqueira, MD PhD, Nadia P Ewing, MD, Christoph Male, MD, Tarek Owaidah, MDFRCPA, Veronica Soto Arellano, MD, Suvankar Majumdar, MBCHB, Mindy Simpson, MD, Mathew Thomas, MD, Ezio Zanon, Marilyn J Manco-Johnson, MD, Monica Martinez, MD, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Rogelio Alejandro Paredes-Aguilera, MD, Alessandra N L Prezotti, MD MSc, Klaus Schmitt, MD, Bulent Zulfikar, Prof, Pier Mannuccio Mannucci, MD, Frits Richard Rosendaal, MD

Blood (2018) 132 (Supplement 1): 384.

https://doi.org/10.1182/blood-2018-99-114599

Published: 2018

Journal Articles

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Frits R. Rosendaal, Roberta Palla, Isabella Garagiola, Pier M. Mannucci, Flora Peyvandi

Blood (2017) 130 (15): 1757–1759.

https://doi.org/10.1182/blood-2017-06-791756

Published: 2017

Includes: Supplemental data

Journal Articles

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Antonino Cannavò, Carla Valsecchi, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Flora Peyvandi

Blood (2017) 129 (10): 1245–1250.

https://doi.org/10.1182/blood-2016-06-720086

Published: 2017

Includes: Supplemental data

Journal Articles

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Frits Rosendaal, MD PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Piermannuccio Mannucci, MD, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 325.

https://doi.org/10.1182/blood.V128.22.325.325

Published: 2016

Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD

Blood (2016) 128 (22): 330.

https://doi.org/10.1182/blood.V128.22.330.330

Published: 2016

Journal Articles

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Blood (2016) 128 (22): 207.

https://doi.org/10.1182/blood.V128.22.207.207

Published: 2016

Journal Articles

Rare bleeding disorders: diagnosis and treatment

Roberta Palla, Flora Peyvandi, Amy D. Shapiro

Blood (2015) 125 (13): 2052–2061.

https://doi.org/10.1182/blood-2014-08-532820

Published: 2015

Journal Articles

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Blood (2014) 124 (21): 2838.

https://doi.org/10.1182/blood.V124.21.2838.2838

Published: 2014

Journal Articles

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Luca A Lotta, Haifeng M Wu, Marie A Scully, Marina Noris, Agnes Veyradier, Ian J Mackie, PhD FRCPath, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, MD, Richard A Gibbs, April Horne, Shangbin Yang, Roberta Palla, Flora Peyvandi

Blood (2011) 118 (21): 2219.

https://doi.org/10.1182/blood.V118.21.2219.2219

Published: 2011

Journal Articles

Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders (EN-RBD),

Blood (2011) 118 (21): 3312.

https://doi.org/10.1182/blood.V118.21.3312.3312

Published: 2011

Journal Articles

ADAMTS13 Activity and Autoantibodies Subclasses as Recurrency Risk Predictors In Acquired Thrombotic Thrombocytopenic Purpura

Giuseppe Bettoni, Luca A Lotta, Dario Consonni, Dino FA Motti, Roberta Palla, Carla Valsecchi, Gloria Casoli, Andrea Rovati, Michele Pizzuti, Flora Peyvandi, MD, PhD

Blood (2010) 116 (21): 2532.

https://doi.org/10.1182/blood.V116.21.2532.2532

Published: 2010

Journal Articles

Values for ADAMTS-13 Activity, Antigen and Autoantibodies in Normal European Controls.

Sabine Geiter, Markus Graf, Elin Tschokert, Agnes Veyradier, Martine Wolf, Claudine Caron, Roberta Palla, PhD, Flora Peyvandi, MD, PhD, Johanna A Kremer Hovinga, MD, Irmela Sulzer, Helga Vetr, PhD

Blood (2009) 114 (22): 4199.

https://doi.org/10.1182/blood.V114.22.4199.4199

Published: 2009

Journal Articles

The Role of B and T Lymphocytes in Recurrent Acquired Thrombotic Thrombocytopenic Purpura.

Mariagabriella Mariani, PhD, Andrea Cairo, Roberta Palla, PhD, Luca Andrea Lotta, MD, Andrea Rovati, MD, Silvia Maria Trisolini, MD, Flora Peyvandi, MD, PhD

Blood (2009) 114 (22): 3521.

https://doi.org/10.1182/blood.V114.22.3521.3521

Published: 2009

Journal Articles

Thrombospondin-1 as a Modulator of ADAMTS13 Activity.

Roberta Palla, PhD, Lombardi Rossana, PhD, Jeffrey I. Zwicker, MD, Jack Lawler, PhD, Raimondo De Cristofaro, MD, Flora Peyvandi, MD, PhD

Blood (2007) 110 (11): 3711.

https://doi.org/10.1182/blood.V110.11.3711.3711

Published: 2007

Journal Articles

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Raimondo De Cristofaro, MD, Flora Peyvandi, MD, Luciano Baronciani, PhD, Roberta Palla, PhD, Silvia Lavoretano, PhD, Rossana Lombardi, PhD, Enrico Di Stasio, MD, Augusto B. Federici, MD, Pier Mannuccio Mannucci, MD

Blood (2006) 108 (11): 333.

https://doi.org/10.1182/blood.V108.11.333.333

Published: 2006

Journal Articles

Risk Factors for Recurrence of Thrombotic Thrombocytopenic Purpura.

Flora Peyvandi, MD, PhD, Silvia Lavoretano, Roberta Palla, Hendrik B. Feys, Tullia Battaglioli, MD, PhD, Carla Valsecchi, Maria T. Canciani, Fabrizio Fabris, MD, Pier M. Mannucci, MD

Blood (2006) 108 (11): 1060.

https://doi.org/10.1182/blood.V108.11.1060.1060

Published: 2006

Journal Articles

The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size

Jeffrey I. Zwicker, Flora Peyvandi, Roberta Palla, Rossana Lombardi, Maria Teresa Canciani, Andrea Cairo, Diego Ardissino, Luisa Bernardinelli, Kenneth A. Bauer, Jack Lawler, Pier Mannucci

Blood (2006) 108 (4): 1280–1283.

https://doi.org/10.1182/blood-2006-04-015701

Published: 2006

Journal Articles

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Flora Peyvandi, MD, PhD, Silvia Lavoretano, PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Carla Valsecchi, PhD, Rossana Lombardi, PhD, Maria T. Canciani, PhD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 3960.

https://doi.org/10.1182/blood.V106.11.3960.3960

Published: 2005

NARROW

Assessing Sequence Similarity between FVIII-Derived B-Cell Epitopes and Pathogen-Derived B-Cell Epitopes and the Risk of Inhibitor Development in Patients with Severe Hemophilia a

Factor VIII Epitope Analysis Using a Random Peptide Phage-Display Library Approach in the Sippet Cohort

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

Rare bleeding disorders: diagnosis and treatment

Prospective Data Collection on Patients with Fibrinogen and Factor XIII Deficiencies: Prelimary Results of the PRO-RBDD Project

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders (EN-RBD),

ADAMTS13 Activity and Autoantibodies Subclasses as Recurrency Risk Predictors In Acquired Thrombotic Thrombocytopenic Purpura

Values for ADAMTS-13 Activity, Antigen and Autoantibodies in Normal European Controls.

The Role of B and T Lymphocytes in Recurrent Acquired Thrombotic Thrombocytopenic Purpura.

Thrombospondin-1 as a Modulator of ADAMTS13 Activity.

Molecular Mapping of the Chloride Binding Site in von Willebrand Factor (VWF): Energetics and Conformational Effects on the ADAMTS-13 Interaction with Wild Type and Type 2B R1306W VWF Forms.

Risk Factors for Recurrence of Thrombotic Thrombocytopenic Purpura.

The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only